Mvasi
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Mvasi, covering 2017-09-14 to 2026-01-27. Get the full timeline:
Most recent: EMA Authorised: Mvasi (bevacizumab) — Amgen Technology (Ireland) UC
6 regulatory and trial events tracked for Mvasi, covering 2017-09-14 to 2026-01-27. Get the full timeline:
Most recent: EMA Authorised: Mvasi (bevacizumab) — Amgen Technology (Ireland) UC